Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study.
Takehiro NodaHidekazu TakahashiMitsuyoshi TeiNaohiro NishidaTaishi HataYutaka TakedaMasayuki OhueHiroshi WadaTsunekazu MizushimaTadafumi AsaokaMamoru UemuraShogo KobayashiKohei MurataTaroh SatohYuichiro DokiHidetoshi Eguchinull nullPublished in: Annals of gastroenterological surgery (2022)
Neoadjuvant chemotherapy for resectable CRLM might prolong the recurrence-free survival period for intermediate-risk patients with preoperative risk scores in the range of 1-10, but the overall survival was not improved by neoadjuvant chemotherapy.